Invention Grant
US08173617B2 RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
有权
RNAi介导的卷曲相关蛋白-1抑制治疗青光眼
- Patent Title: RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
- Patent Title (中): RNAi介导的卷曲相关蛋白-1抑制治疗青光眼
-
Application No.: US13084944Application Date: 2011-04-12
-
Publication No.: US08173617B2Publication Date: 2012-05-08
- Inventor: Abbot F. Clark , Wan-Heng Wang , Loretta Graves McNatt , Jon E. Chatterton
- Applicant: Abbot F. Clark , Wan-Heng Wang , Loretta Graves McNatt , Jon E. Chatterton
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Jason J. Derry
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/02 ; C07H21/04 ; C12N15/63

Abstract:
RNA interference is provided for inhibition of Frizzled Related Protein-1 mRNA expression, in particular, for treating patients having glaucoma or at risk of developing glaucoma.
Public/Granted literature
- US20110190381A1 RNAI-MEDIATED INHIBITION OF FRIZZLED RELATED PROTEIN-1 FOR TREATMENT OF GLAUCOMA Public/Granted day:2011-08-04
Information query